Plain-English translation of NCT05292339 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether ketorolac, an anti-inflammatory medication, works as well as or better than triamcinolone (a steroid) when injected directly into joints and tendons of the upper arm and hand. Both medications are already used in clinical practice to reduce pain and inflammation. The study wants to see which one gives patients better relief and lasting improvement in their ability to use their arms and hands.
Shoulder, elbow, wrist, and hand arthritis and tendon problems cause significant pain and disability, with no cure currently available. While steroid injections are commonly used for larger joints like the knee and hip, there is limited research on which medication works best for the smaller joints and tendons of the upper extremity, and this medication has been shown to help in other joints but needs more study in this area.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive either a ketorolac or triamcinolone injection into the affected joint or tendon area. Your doctor will perform the injection using standard technique, just as they would in regular care. You will then be monitored to see how well the medication works for reducing your pain and improving your ability to move and use your arm or hand over time.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States